US Patent Issued to MEDICINAL GENOMICS on Aug. 19 for "Methods and kits for classifying cannabinoid production in cannabis plants" (Massachusetts Inventor)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,999, issued on Aug. 19, was assigned to MEDICINAL GENOMICS Corp. (Beverly, Mass.).

"Methods and kits for classifying cannabinoid production in cannabis plants" was invented by Kevin McKernan (Marblehead, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods and kits for characterizing Cannabis plants. Methods and kits of the present disclosure include detection/amplification of one or more enzymes involved in the production of cannabinoids, such as, for example, tetrahydrocannabinolic acid (THCA) synthase and/or cannabidiolic acid (CBDA) synthase."

The patent was filed on June 14, 2021, under Application No. 1...